Urgent

Phenytoin toxicity

Anticonvulsant · Toxicology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Dose-related toxicity (chronic accumulation or overdose) causing cerebellar signs - nystagmus, ataxia, dysarthria - and, with rapid IV administration, cardiovascular collapse.

Red flags

  • Cardiovascular collapse during IV loading (the "purple glove" and hypotension are infusion-related)
  • Severe ataxia with aspiration risk
  • Very high levels with coma

Assessment

Differential diagnosis

  • Alcohol intoxication
  • Cerebellar stroke
  • Other anticonvulsant toxicity
  • Vestibular disorder

Investigations

  • Phenytoin level (total and, if hypoalbuminaemic, free level)
  • Albumin, U&E, LFTs
  • ECG if IV toxicity (bradycardia, hypotension)
  • Glucose

Management

  • Withhold phenytoin; supportive care - most oral toxicity is self-limiting
  • For IV-related cardiovascular toxicity: stop infusion, IV fluids, treat bradycardia/hypotension
  • Consider multiple-dose activated charcoal for large oral overdose
  • Fall/aspiration precautions for ataxia and reduced consciousness
  • Correct for low albumin when interpreting levels

Drugs & doses

Supportive care (mainstay)
Multiple-dose activated charcoal for significant oral overdose
IV fluids/atropine for IV-infusion-related cardiovascular toxicity
Benzodiazepines if agitated

Disposition

Observe/admit until levels falling and ataxia improving; ICU for cardiovascular toxicity.

Complications & pitfalls

  • Aspiration
  • Prolonged ataxia
  • IV-related hypotension/arrhythmia and tissue injury

Exam pearls

  • Cardiovascular toxicity is largely from the IV vehicle and rapid infusion - oral overdose rarely causes it.
  • Correct total levels for hypoalbuminaemia or measure free phenytoin.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.